Irhythm Technologies, Inc.

  • Moat Score
  • Safety Score
  • Market Cap $4.27B
  • PE -43
  • Debt $647.24M
  • Cash $383.64M
  • EV $4.53B
  • FCF $13.94M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$98.32M
EBIT-$104.62M
ROE-113%
ROA-11%
FCF$13.94M
Equity$86.67M
Growth Stability1
PE-43.44
PB49.28
P/FCF306.32
P/S6.9
Price/Cash0.09
Debt/Equity7.47
Debt/FCF46.42
Net Margins-19%
Gross Margins69%
Op. Margins-17%
Sales Growth YoY20%
Sales Growth QoQ-3%
Sales CAGR31%
Equity CAGR10%
Earnings Growth YoY-33%
Earnings Growth QoQ2K%
Sales CAGR 5Y23%
Equity CAGR 5Y-23%
Earnings CAGR 3Y21%
Sales CAGR 3Y21%
Equity CAGR 3Y-39%
Market Cap$4.27B
Revenue$618.59M
Assets$926.10M
Total Debt$647.24M
Cash$383.64M
Shares Outstanding31.59M
EV4.53B
Moat Score3%
Safety Score56%
Working Capital524.67M
Current Ratio5.71
Gross Profit$429.23M
Shares Growth 3y2%
Equity Growth QoQ-5%
Equity Growth YoY-4%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The companys portfolio include ambulatory cardiac monitoring services on a platform called the Zio service which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

SEC Filings

Direct access to Irhythm Technologies, Inc. (IRTC) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2025
    • 10-Q Mar 31
  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Irhythm Technologies, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Irhythm Technologies, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Irhythm Technologies, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Irhythm Technologies, Inc..

= $139M
012345678910TV
fcf$14M$14M$14M$14M$14M$14M$14M$14M$14M$14M$14M$139M
DCF$13M$12M$10M$9.5M$8.7M$7.9M$7.2M$6.5M$5.9M$5.4M$54M
Value$139M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins-63%-33%-30%-33%-25%-17%-31%-28%-25%-19%-19%
ROA--11%-20%-36%-17%-8%-22%-25%-28%-12%-11%
ROE--23%-37%-89%-40%-13%-36%-48%-59%-125%-113%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF--2.39-2.5-1.02-0.83-1.21-0.32-0.66-0.39-21.1646.42
Debt over Equity-0.30.50.580.640.260.10.080.150.177.117.47
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-77%54%50%46%24%22%27%20%20%23%
Earnings YoY growth--8%41%64%13%-20%131%15%6%-8%-
Equity YoY growth--191%-14%-32%149%152%-18%-14%-12%-57%-23%
FCF YoY growth--2%-5%85%24%-35%141%-20%71%-66%-